JP2024507540A5 - - Google Patents
Info
- Publication number
- JP2024507540A5 JP2024507540A5 JP2023550601A JP2023550601A JP2024507540A5 JP 2024507540 A5 JP2024507540 A5 JP 2024507540A5 JP 2023550601 A JP2023550601 A JP 2023550601A JP 2023550601 A JP2023550601 A JP 2023550601A JP 2024507540 A5 JP2024507540 A5 JP 2024507540A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- car
- sequence
- heavy chain
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163153884P | 2021-02-25 | 2021-02-25 | |
| US63/153,884 | 2021-02-25 | ||
| PCT/US2022/018029 WO2022183074A2 (en) | 2021-02-25 | 2022-02-25 | Anti-psma antibodies and car-t structures |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507540A JP2024507540A (ja) | 2024-02-20 |
| JP2024507540A5 true JP2024507540A5 (cg-RX-API-DMAC7.html) | 2025-03-04 |
Family
ID=80819665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550601A Pending JP2024507540A (ja) | 2021-02-25 | 2022-02-25 | 抗psma抗体及びcar-t構造 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240226162A9 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4298130A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024507540A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230148828A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117500835A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022226277A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3211138A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023009874A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022183074A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109862784A (zh) | 2016-08-24 | 2019-06-07 | 特尼奥生物股份有限公司 | 产生经修饰的仅有重链的抗体的转基因非人动物 |
| EP3559035A1 (en) | 2016-12-21 | 2019-10-30 | TeneoBio, Inc. | Anti-bcma heavy chain-only antibodies |
| EA202091557A1 (ru) | 2017-12-22 | 2020-11-18 | Тенеобио, Инк. | Антитела, содержащие только тяжелые цепи, которые связываются с cd22 |
| CA3133654A1 (en) | 2019-04-05 | 2020-10-08 | Teneobio, Inc. | Heavy chain antibodies binding to psma |
| CN114206927B (zh) | 2019-06-14 | 2025-03-21 | 特尼奥生物股份有限公司 | 与cd22和cd3结合的多特异性重链抗体 |
| TW202442689A (zh) | 2023-03-03 | 2024-11-01 | 美商亞森諾生物科學公司 | 靶向psma及ca9之系統 |
| WO2025183244A1 (ko) * | 2024-02-29 | 2025-09-04 | 주식회사 피비앱셀 | Psma에 대한 항체 및 그의 용도 |
| WO2026107088A1 (en) * | 2024-11-13 | 2026-05-21 | Poseida Therapeutics, Inc. | Dual car constructs and methods of use |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| CA2249195A1 (en) | 1996-03-18 | 1997-09-25 | Board Of Regents, The University Of Texas System | Immunoglobin-like domains with increased half lives |
| GB0115256D0 (en) | 2001-06-21 | 2001-08-15 | Babraham Inst | Mouse light chain locus |
| MXPA05004677A (es) | 2002-10-31 | 2005-11-17 | Genentech Inc | Metodos y composiciones para aumentar la produccion de anticuerpos. |
| WO2004065417A2 (en) | 2003-01-23 | 2004-08-05 | Genentech, Inc. | Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture |
| EP1776383B1 (en) | 2004-07-22 | 2014-08-20 | Erasmus University Medical Center Rotterdam | Binding molecules |
| US20160355591A1 (en) | 2011-05-02 | 2016-12-08 | Immunomedics, Inc. | Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies |
| US20100122358A1 (en) | 2008-06-06 | 2010-05-13 | Crescendo Biologics Limited | H-Chain-only antibodies |
| CN102421801B (zh) | 2009-03-10 | 2016-03-16 | 比奥根Ma公司 | 抗-bcma抗体 |
| GB0905023D0 (en) | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
| US9345661B2 (en) | 2009-07-31 | 2016-05-24 | Genentech, Inc. | Subcutaneous anti-HER2 antibody formulations and uses thereof |
| JP2019506155A (ja) * | 2016-01-12 | 2019-03-07 | クレッシェンド、バイオロジックス、リミテッドCrescendo Biologics Limited | 治療分子 |
| IL299221A (en) | 2016-06-21 | 2023-02-01 | Teneobio Inc | Cd3 binding antibodies |
| CN109862784A (zh) | 2016-08-24 | 2019-06-07 | 特尼奥生物股份有限公司 | 产生经修饰的仅有重链的抗体的转基因非人动物 |
| CR20220578A (es) | 2016-09-14 | 2023-01-17 | Teneobio Inc | Anticuerpos de unión a cd3 |
| AU2019274654B2 (en) * | 2018-05-23 | 2023-07-20 | Pfizer Inc. | Antibodies specific for CD3 and uses thereof |
| CA3133654A1 (en) * | 2019-04-05 | 2020-10-08 | Teneobio, Inc. | Heavy chain antibodies binding to psma |
-
2022
- 2022-02-25 WO PCT/US2022/018029 patent/WO2022183074A2/en not_active Ceased
- 2022-02-25 US US18/547,665 patent/US20240226162A9/en active Pending
- 2022-02-25 JP JP2023550601A patent/JP2024507540A/ja active Pending
- 2022-02-25 AU AU2022226277A patent/AU2022226277A1/en active Pending
- 2022-02-25 KR KR1020237031488A patent/KR20230148828A/ko active Pending
- 2022-02-25 MX MX2023009874A patent/MX2023009874A/es unknown
- 2022-02-25 EP EP22711728.0A patent/EP4298130A2/en active Pending
- 2022-02-25 CN CN202280016722.9A patent/CN117500835A/zh active Pending
- 2022-02-25 CA CA3211138A patent/CA3211138A1/en active Pending